Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Magnesium Sulfate for PPHN
NCT04328636Phase 2Completed
- Sponsor
- Sohag University
- Start
- Nov 2017
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of magnesium sulfate in persistent pulmonary hypertension of the newborn (PPHN), sponsored by Sohag University. Started Nov 2017; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on NCT04328636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04328636.